Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 100%

<iframe
  src="https://statesidedaily.com/embed/cluster/0d64febf518ff99a4f4747250ceb933849d11ce8"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 100%"></iframe>